Skip to main content
. 2022 Apr 1;9:802719. doi: 10.3389/fmed.2022.802719

FIGURE 1.

FIGURE 1

(A) Sample selection and collection. Infectious fluids and tissues can be taken under the evaluation of clinicians. (B–D) Experimental procedures (wet lab) of mNGS, mainly including sample processing and DNA/RNA extraction, DNA libraries construction, and sequencing. (E) Bioinformatic analysis (dry lab) of mNGS. With the analysis pipeline modification, it is promising to determine tuberculosis, co-infection, comorbidity, and antibiotics resistance simultaneously. (F) Clinical decision. After obtaining the report, clinical assessment and treatment adjustment can be made promptly.